Regional Powerhouses: An In-Depth Look at the CRISPR Technology Market Region Performance for 2026
The geographical distribution of gene-editing innovation is shifting. While North America—specifically the Boston-Cambridge and San Francisco hubs—continues to lead in total R&D spending, the Asia-Pacific region is catching up with astonishing speed. Governments in China and Singapore have designated "Genomic Medicine" as a strategic pillar of their national economies, providing...
0 Comments 0 Shares 1K Views 0 Reviews